Skip to main content
A prairie rattlesnake coils into striking position, flicking its forked tongue in and out on a sunny, dry hillside.
Crotalus viridis (prairie rattlesnake) iStock.com/HRossD

Toxicology Case Files from the Utah Poison Control Center

Teaching Points

  • Envenomation by several species of rattlesnakes may cause neuromuscular findings including myokymia, fasciculations, and muscle weakness
  • Antivenom has mixed efficacy in treating neurotoxicity
  • Care is supportive including intubation and ventilation in cases of respiratory failure

Case

A 19-month-old male was bit by a rattlesnake on the face near his home in Montana. Family witnessed the bite. He was taken to a small local ED and had swelling around his forehead and eyes. He was treated with Crotalidae polyvalent immune fab (ovine), also known as CroFab, and transferred to a larger Montana hospital. There he received a dose of Crotalidae immune F(ab’)2 (equine), also known as Anavip. He was intubated for airway protection due to some stridor prior to transport. The swelling had progressed to his upper cheek but did not involve the airway. No abnormal movements or ventilatory compromise were noted. He was transferred to a tertiary care center.

He did not develop any coagulopathy with normal platelets, fibrinogen, and PTT throughout his course. He did not require any further antivenom to control swelling. He was extubated after 24 hours. About 36 hours after arrival, he developed diffuse twitching movements involving the entire body. He had normal respiratory effort and preserved consciousness. His CK was normal. He had no response to midazolam. He received additional maintenance doses of both types of antivenom without any change. His symptoms resolved spontaneously, and he was discharged home about 4 days after the envenomation.

Rattlesnake Neurotoxins

The child was bitten by a Prairie rattlesnake, Crotalus viridis, the only rattlesnake species found near his home in Montana. While several rattlesnakes are known to cause various forms of neurotoxicity, there are no published reports in the literature of Prairie rattlesnakes causing such effects.

The Mojave rattlesnake, C. scutulatus, is well-known to cause myokymia (see video)1 or a rippling movement of the muscles and may cause respiratory paralysis.2 Other rattlesnake species known to produce neurotoxicity include the Timber (C. horridus), Southern Pacific (C. oreganus), Sidewinder (C. cerastes), and Midget faded (C. oreganus concolor).3 Neurotoxicity is not reported from the Great Basin rattlesnake (C. lotusus), the species most often responsible for bites in Northern Utah.

Mojave toxin, a phospholipase A2 presynaptic toxin which blocks neurotransmitter release, is the venom component responsible for neurotoxicity in Mojave, Timber, Southern Pacific, and Midget faded rattlesnakes.

Prairie rattlesnake venom contains Myotoxin A which opens muscle sodium channels. In animal models it is known to cause hindlimb paralysis.4 This toxin may compromise more than 50% of Prairie rattlesnake venom.5

Both rattlesnake antivenoms available in the United States have limited in vitro binding of these myotoxins. Case reports show mixed efficacy in reversing neuromuscular effects. Care is primarily supportive, with respiratory failure requiring intubation occurring in some cases.

For assistance in managing a suspected rattlesnake envenomation, call the Utah Poison Control Center at any time 24/7 at 1-800-222-1222.

References

  1. Garg A, Kaur B, Cheema Y S, et al. (August 02, 2021) Video Presentation of Myokymia in a Snakebite. Cureus 13(8): e16844. doi:10.7759/cureus.16844
  2. Massey DJ, Calvete JJ, Sánchez EE, Sanz L, Richards K, Curtis R, Boesen K. Venom variability and envenoming severity outcomes of the Crotalus scutulatus scutulatus (Mojave rattlesnake) from Southern Arizona. J Proteomics. 2012 May 17;75(9):2576-87. doi: 10.1016/j.jprot.2012.02.035. Epub 2012 Mar 15. PMID: 22446891.
  3. Levine M, Tashman D, Recchio I, Friedman N, Seltzer J, Minns A, LoVecchio F. Neurotoxicity Associated With the Southern Pacific Rattlesnake (Crotalushelleri). Ann Emerg Med. 2023 Mar;81(3):318-322. doi: 10.1016/j.annemergmed.2022.08.020. Epub 2022 Oct 15. PMID: 36253294.
  4. Hong SJ, Chang CC. Electrophysiological studies of myotoxin a, isolated from prairie rattlesnake (Crotalus viridis viridis) venom, on murine skeletal muscles. Toxicon. 1985 Jan 1;23(6):927-37.
  5. Smith, C. (2021). Biochemical Ecology of the Western Rattlesnakes: Venom Variation and Toxin Profiling of the Crotalus Viridis/Oreganus/Scutulatus Complex (Order No. 28867389). Available from ProQuest One Academic. (2621280157). https://www.proquest.com/dissertations-theses/biochemical-ecology-western-rattlesnakes-venom/docview/2621280157/se-2

Author: Michael Moss, MD, FAACT, Medical Director, Utah Poison Control Center

Search